Pinnacle Wealth Management LLC purchased a new stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 55,585 shares of the health services provider's stock, valued at approximately $442,000.
Other large investors have also added to or reduced their stakes in the company. Golden State Wealth Management LLC boosted its holdings in Teladoc Health by 102.6% in the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after acquiring an additional 1,690 shares in the last quarter. National Bank of Canada FI lifted its position in Teladoc Health by 79.4% during the first quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock valued at $28,000 after buying an additional 1,581 shares during the period. Sterling Capital Management LLC lifted its position in Teladoc Health by 776.7% during the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock valued at $42,000 after buying an additional 4,101 shares during the period. Brucke Financial Inc. purchased a new position in Teladoc Health during the fourth quarter valued at $92,000. Finally, Westside Investment Management Inc. lifted its position in Teladoc Health by 16.8% during the first quarter. Westside Investment Management Inc. now owns 10,750 shares of the health services provider's stock valued at $86,000 after buying an additional 1,550 shares during the period. Institutional investors own 76.82% of the company's stock.
Analysts Set New Price Targets
Several equities analysts have commented on TDOC shares. Wells Fargo & Company lowered their price objective on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating for the company in a research report on Thursday, May 8th. Mizuho started coverage on Teladoc Health in a research report on Friday, July 25th. They set a "neutral" rating and a $10.00 price objective for the company. Canaccord Genuity Group lowered their price objective on Teladoc Health from $14.00 to $12.00 and set a "buy" rating for the company in a research report on Thursday, May 1st. Stifel Nicolaus lowered their price objective on Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a research report on Thursday, May 1st. Finally, Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a research report on Thursday, May 1st. Six equities research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $9.75.
Check Out Our Latest Analysis on TDOC
Insiders Place Their Bets
In other Teladoc Health news, insider Adam C. Vandervoort sold 5,808 shares of the business's stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $39,842.88. Following the completion of the transaction, the insider owned 69,773 shares of the company's stock, valued at approximately $478,642.78. The trade was a 7.68% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Carlos Nueno sold 3,958 shares of the business's stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $27,151.88. Following the completion of the transaction, the insider directly owned 17,645 shares of the company's stock, valued at approximately $121,044.70. This trade represents a 18.32% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 18,656 shares of company stock valued at $128,189. 0.58% of the stock is owned by insiders.
Teladoc Health Stock Up 6.7%
Shares of TDOC traded up $0.4840 during trading hours on Friday, hitting $7.6740. The company had a trading volume of 6,042,388 shares, compared to its average volume of 7,193,715. The firm has a fifty day moving average price of $7.73 and a 200-day moving average price of $8.22. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67. The stock has a market capitalization of $1.36 billion, a price-to-earnings ratio of -6.45 and a beta of 1.76. Teladoc Health, Inc. has a 52-week low of $6.35 and a 52-week high of $15.21.
Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.27) by $0.08. The firm had revenue of $631.90 million during the quarter, compared to analyst estimates of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.Teladoc Health's quarterly revenue was down 1.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.38) EPS. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. On average, equities research analysts forecast that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.
Teladoc Health Profile
(
Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Read More

Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.